Insmed (INSM) Operating Margin (QoQ) (2011 - 2026)

Insmed (INSM) Operating Margin (QoQ) (2011 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn
4 NuCana 279.75 Bn 279.75 Bn -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn
7 Belite Bio 62.51 Bn 62.51 Bn -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn
9 Revolution Medicines 37.78 Bn 37.78 Bn -
10 Insmed 23.26 Bn 22.03 Bn 258.54 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 7,108.00
Dec 31, 2025 13,594.00
Sep 30, 2025 3,415.00
Jun 30, 2025 -2,395.00
Mar 31, 2025 -4,671.00
Dec 31, 2024 784.00
Sep 30, 2024 9,135.00
Jun 30, 2024 -12,707.00
Mar 31, 2024 2,029.00
Dec 31, 2023 -2,626.00
Sep 30, 2023 11,822.00
Jun 30, 2023 -7,779.00
Mar 31, 2023 2,825.00
Dec 31, 2022 -6,690.00
Sep 30, 2022 -5,313.00
Jun 30, 2022 3,374.00
Mar 31, 2022 738.00
Dec 31, 2021 4,507.00
Sep 30, 2021 -2,638.00
Jun 30, 2021 1,324.00